Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M.-A. Dominguez
Observed names:
Dominguez, M.-A.,
M. Dominguez,
Maia Dominguez
Institution:
Reaction Biology Corporation (United States)
Observed institution:
Reaction Biology Corporation (United States)
OpenAlex ID:
A5113212830
Abstract 938: Screening the entire kinase-directed, FDA-approved pharmacopeia against the largest collection of wild-type and mutant kinases reveals many opportunities for drug repurposing and targeted therapy
2024
·
Christian M. Loch
, Shuguang Liang
, et al.
·
Cancer Research
·
1
Pin5 Real World Experience With Dolutegravir-based Two-drug Regimens
2019
·
C. Garris
, S. Dhir
, et al.
·
Value in Health
Discovery of a Potent, Selective, and Orally Available PI3K delta Inhibitor for the Treatment of Inflammatory Diseases.
2017
·
Montse Erra
, Joan Taltavull
, et al.
·
ACS Medicinal Chemistry Letters
CCDC 157944: Experimental Crystal Structure Determination
2000
·
Rojas-Lima, S.
, Santillan, R.L.
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
